Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2020-09-21 Major Shareholding Noti…
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details a proposed inter-se transfer of equity shares within the promoter group of Strides Pharma Science Ltd. The content includes specifics about the acquirer, seller, number of shares, price, and regulatory compliance declarations. This type of document is a notification related to changes in significant share ownership levels, specifically under takeover regulations. It is not a financial report, earnings release, or management report, but a regulatory filing about share acquisition and promoter shareholding changes. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ).
2020-09-21 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-09-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding a shareholder's request for the issuance of duplicate share certificates due to loss of original certificates. It references Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is focused on procedural information about share certificates and does not contain financial data, earnings, management discussion, or any report publication. It is not an announcement of a report but a regulatory disclosure related to share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-16 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication from a company secretary to stock exchanges regarding the receipt of requests for issuance of duplicate share certificates due to loss of original certificates. It references Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is focused on shareholder share certificate issues and procedural updates, not on financial results, management changes, or other report types. It is not a financial report, earnings release, or management discussion. It is also not a voting result or capital change announcement. The document is a regulatory announcement related to share certificate issuance under SEBI regulations, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance-related disclosure.
2020-09-15 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces a transaction where Strides Pharma Science Limited is unveiling SteriScience as its dedicated arm for sterile injectables, including details about the acquisition such as the target entity, consideration, shareholding, and background. The document is an announcement of a capital investment and acquisition-related update rather than a full financial report or detailed merger filing. It fits best under Capital/Financing Update (CAP) as it provides information on the company's investment and capital allocation related to a new business arm.
2020-09-14 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release dated September 14, 2020, announcing Strides Pharma Science Limited's investment in SteriScience as its dedicated arm for sterile injectables. It details the company's strategic plans, joint ventures, investment amounts, and market opportunities. The content is focused on business updates and strategic initiatives rather than financial results or regulatory filings. It is not an earnings release, annual report, or interim report. It is also not a regulatory filing, audit report, or management change announcement. The document is a corporate press release providing a capital/financing update and strategic business development information. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2020-09-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.